Tirzepatide-Associated Severe Hepatocellular Injury: A Case Report and Diagnostic Considerations.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
tirzepatide
drug-induced-liver-injury
case-report
hepatotoxicity
obesity
type-2-diabetes
